Published in Br J Cancer on February 02, 2001
Epidemiology of gastric cancer. World J Gastroenterol (2006) 7.67
Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol (2012) 1.53
Multifactorial etiology of gastric cancer. Methods Mol Biol (2012) 1.29
The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification. Gastric Cancer (2011) 1.27
Survival and surgical outcomes after laparoscopy-assisted total gastrectomy for gastric cancer: case-control study. Surg Endosc (2012) 1.12
Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer. BMC Cancer (2010) 1.09
Trend in gastric cancer: 35 years of surgical experience in Japan. World J Gastroenterol (2011) 1.05
Clinical profile of gastric cancer in Khuzestan, southwest of Iran. World J Gastroenterol (2006) 0.99
MicroRNAs in gastric cancer: from benchtop to bedside. Dig Dis Sci (2013) 0.99
Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori. J Clin Pathol (2006) 0.98
Clinical epidemiology of gastric cancer. Singapore Med J (2014) 0.95
Multimodal treatment of gastric cancer in the west: Where are we going? World J Gastroenterol (2015) 0.92
Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value. World J Gastroenterol (2014) 0.92
Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer. Int J Clin Exp Pathol (2014) 0.90
Gastric malignancies in Northern Jordan with special emphasis on descriptive epidemiology. World J Gastroenterol (2004) 0.86
Clinical application of microRNA in gastric cancer in Eastern Asian area. World J Gastroenterol (2013) 0.85
Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer. Fam Cancer (2015) 0.84
Incidence of stomach cancer in oman and the other gulf cooperation council countries. Oman Med J (2011) 0.81
Trends in gastric cancer incidence: a period and birth cohort analysis in a well-defined French population. Gastric Cancer (2015) 0.81
Time trends of incidence of digestive system cancers in changle of China during 1988-2002. World J Gastroenterol (2006) 0.81
Clinical significance of RacGAP1 expression at the invasive front of gastric cancer. Gastric Cancer (2014) 0.80
Advanced gastric cancer in jordan from 2004 to 2008: a study of epidemiology and outcomes. Gastrointest Cancer Res (2011) 0.80
Lauren classification and individualized chemotherapy in gastric cancer. Oncol Lett (2016) 0.79
Epidemiology of gastric cancer in the gangetic areas of west bengal. ISRN Gastroenterol (2013) 0.76
Matrix metalloproteinase 9 gene polymorphisms are associated with a multiple family history of gastric cancer. Gastric Cancer (2016) 0.76
A polymorphism at the microRNA binding site in the 3'-untranslated region of C14orf101 is associated with the risk of gastric cancer development. Exp Ther Med (2016) 0.76
The current situation for gastric cancer in Chile. Ecancermedicalscience (2016) 0.75
Ecological study of gastric cancer in Brazil: geographic and time trend analysis. World J Gastroenterol (2014) 0.75
Tumor specificity and in vivo targeting of an antibody against exon 9 deleted E-cadherin in gastric cancer. J Cancer Res Clin Oncol (2007) 0.75
Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89
THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand (1965) 22.65
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med (1991) 11.98
The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev (1986) 5.10
Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol (1999) 3.01
Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology (1992) 2.83
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst (1991) 2.23
Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areas. Cancer (1993) 2.09
Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol (1992) 1.76
Histologic types of gastric carcinoma in high- and low-risk areas. Int J Cancer (1968) 1.73
Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer (1994) 1.68
Time trends of intestinal and diffuse types of gastric cancer in the United States. Int J Cancer (1971) 1.22
An ecological study on diet/nutrition and cancer in Japan. Int J Cancer (1997) 1.16
Helicobacter pylori and gastric cancer: what is the real risk? Gastroenterologist (1998) 1.16
Gastric cancer in a high-risk area in Italy. Histopathologic patterns according to Lauren's classification. Cancer (1988) 1.07
Epidemiology of stomach cancer in Japan. With special reference to the strategy for the primary prevention. Jpn J Clin Oncol (1984) 0.97
Decreasing trend of stomach cancer in Japan. Jpn J Cancer Res (1987) 0.87
The decline in the incidence of stomach cancer in Sweden 1960-1984: a birth cohort phenomenon. Int J Cancer (1991) 0.86
Reduced incidence of Helicobacter pylori infection in young Japanese persons between the 1970s and the 1990s. J Clin Gastroenterol (1997) 0.85
Cancer incidence in Japan in 1975 and changes of epidemiological features for cancer in Osaka. Natl Cancer Inst Monogr (1982) 0.82
Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med (1988) 7.12
Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). J Immunol (1987) 5.64
Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. BMJ (2005) 4.91
Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A (1991) 4.56
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res (2007) 4.41
Detection of Mycobacterium tuberculosis in clinical specimens by polymerase chain reaction and Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test. J Clin Microbiol (1993) 4.04
Leucine zipper structure of the protein CRE-BP1 binding to the cyclic AMP response element in brain. EMBO J (1989) 3.56
Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today (1990) 3.31
Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol (1990) 3.26
Epidemiologic study on Yusho, a Poisoning Caused by Ingestion of Rice Oil Contaminated with a Commercial Brand of Polychlorinated Biphenyls. Environ Health Perspect (1972) 2.42
Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J Biochem (1994) 2.06
Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol (1994) 1.92
The indirect association of human T-cell leukemia virus tax protein with DNA results in transcriptional activation. J Virol (1991) 1.85
Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem (1997) 1.85
Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. Proc Natl Acad Sci U S A (1989) 1.81
Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]). Am J Respir Cell Mol Biol (1990) 1.76
Seronegative Lambert-Eaton myasthenic syndrome: study of 110 Japanese patients. Neurology (2002) 1.67
Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. J Clin Invest (1995) 1.65
Proteasomes (multi-protease complexes) as 20 S ring-shaped particles in a variety of eukaryotic cells. J Biol Chem (1988) 1.61
Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. J Immunol (1990) 1.61
Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol (1993) 1.53
Macrophages cultured in vitro release leukotriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan. J Clin Invest (1990) 1.49
Production and characterization of recombinant human neutrophil chemotactic factor. J Biochem (1989) 1.47
New method to measure telomerase activity by transcription-mediated amplification and hybridization protection assay. Clin Chem (1998) 1.46
Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunopathol (1993) 1.45
A new method for the preparation of acyl-CoA thioesters. J Biochem (1981) 1.45
Macrophage stimulating protein: purification, partial amino acid sequence, and cellular activity. J Exp Med (1991) 1.43
Cysteine sulfinate desulfinase, a NIFS-like protein of Escherichia coli with selenocysteine lyase and cysteine desulfurase activities. Gene cloning, purification, and characterization of a novel pyridoxal enzyme. J Biol Chem (1997) 1.43
Expression of CCR6 and CD83 by cytokine-activated human neutrophils. Blood (2000) 1.40
Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J Biol Chem (1999) 1.39
Proteasomes: protein and gene structures. New Biol (1992) 1.39
The 15-Country Collaborative Study of Cancer Risk Among Radiation Workers in the Nuclear Industry: design, epidemiological methods and descriptive results. Radiat Res (2007) 1.37
High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Res (1996) 1.36
The relationship between lifestyle, social characteristics and obesity in 3-year-old Japanese children. Child Care Health Dev (1999) 1.32
Dietary factors and stomach cancer mortality. Br J Cancer (2002) 1.31
Post-load glucose measurements in oral glucose tolerance tests correlate well with 1,5-anhydroglucitol, an indicator of overall glycaemic state, in subjects with impaired glucose tolerance. Clin Sci (Lond) (2001) 1.30
Transfer of polychlorinated biphenyls from mothers to foetuses and infants. Food Cosmet Toxicol (1978) 1.27
Molecular cloning of cDNA for proteasomes (multicatalytic proteinase complexes) from rat liver: primary structure of the largest component (C2). Biochemistry (1989) 1.27
Intra-alveolar macrophage-inflammatory peptide 2 induces rapid neutrophil localization in the lung. Am J Respir Cell Mol Biol (1996) 1.25
Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J Clin Invest (1992) 1.25
Kinetic and mutational studies of three NifS homologs from Escherichia coli: mechanistic difference between L-cysteine desulfurase and L-selenocysteine lyase reactions. J Biochem (2000) 1.24
Consumption of toxic rice oil by 'yusho' patients and its relation to the clinical response and latent period. Food Cosmet Toxicol (1979) 1.23
Idiopathic Parkinsonism with Lewy-type inclusions in cerebral cortex. A case report. Acta Neuropathol (1978) 1.23
Secretion of neutrophil attractant/activation protein by lipopolysaccharide-stimulated lung macrophages determined by both enzyme-linked immunosorbent assay and N-terminal sequence analysis. Am Rev Respir Dis (1990) 1.22
The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats. J Pathol (1997) 1.22
Macrophage-stimulating protein inhibits induction of nitric oxide production by endotoxin- or cytokine-stimulated mouse macrophages. J Biol Chem (1994) 1.21
Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol (2009) 1.20
Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T-->C mutation associated with coronary spastic angina. Hum Mol Genet (2000) 1.19
Proteasomes are essential for yeast proliferation. cDNA cloning and gene disruption of two major subunits. J Biol Chem (1990) 1.19
Neutrophil attractant/activation protein-1 (NAP-1) causes human basophil histamine release. Immunol Lett (1989) 1.19
Allelic imbalance and mutations of the PTEN gene in ovarian cancer. Int J Cancer (2000) 1.16
Rho-kinase mediates angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. Hypertension (2001) 1.15
MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol (1993) 1.15
The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-alpha-induced expression of monocyte-chemoattractant protein-1 in endothelial cells. Blood (1999) 1.15
Molecular and structural requirements of a lipoteichoic acid from Enterococcus hirae ATCC 9790 for cytokine-inducing, antitumor, and antigenic activities. Infect Immun (1995) 1.14
Proteolytic conversion of single chain precursor macrophage-stimulating protein to a biologically active heterodimer by contact enzymes of the coagulation cascade. J Biol Chem (1994) 1.14
Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis. Circulation (2000) 1.14
The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines. J Invest Dermatol (1997) 1.13
Prospective study of diabetes mellitus and liver cancer in Japan. Diabetes Metab Res Rev (2001) 1.13
Isolation of novel GRO genes and a phylogenetic analysis of the CXC chemokine subfamily in mammals. Mol Biol Evol (1999) 1.13
Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1. J Invest Dermatol (1991) 1.13
Yusho, a poisoning caused by rice oil contaminated with polychlorinated biphenyls. HSMHA Health Rep (1971) 1.13
Molecular cloning of cDNA for proteasomes from rat liver: primary structure of component C3 with a possible tyrosine phosphorylation site. Biochemistry (1990) 1.12
Phenotypic and functional change of cytokine-activated neutrophils: inflammatory neutrophils are heterogeneous and enhance adaptive immune responses. J Leukoc Biol (2001) 1.12
Possible mechanism of nuclear translocation of proteasomes. FEBS Lett (1990) 1.11
Demonstration that a human 26S proteolytic complex consists of a proteasome and multiple associated protein components and hydrolyzes ATP and ubiquitin-ligated proteins by closely linked mechanisms. Eur J Biochem (1992) 1.11
Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer (2005) 1.09
Arsenic contamination of groundwater and prevalence of arsenical dermatosis in the Hetao plain area, Inner Mongolia, China. Mol Cell Biochem (2001) 1.09
Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis. Tuberculosis (Edinb) (2005) 1.07
Production and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation. Infect Immun (2006) 1.07
MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-alpha plays a role in maximal MCP-1 mRNA expression. J Leukoc Biol (1999) 1.07
Functional characterization of alanine racemase from Schizosaccharomyces pombe: a eucaryotic counterpart to bacterial alanine racemase. J Bacteriol (2001) 1.07
Synthesis and biological characterization of monocyte-derived neutrophil chemotactic factor. FEBS Lett (1988) 1.06
Tumor-derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors. Am J Pathol (1994) 1.06
Tyrosine 265 of alanine racemase serves as a base abstracting alpha-hydrogen from L-alanine: the counterpart residue to lysine 39 specific to D-alanine. J Biochem (1999) 1.06
Molecular organization of a high molecular weight multi-protease complex from rat liver. J Mol Biol (1988) 1.05
Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases. Hum Pathol (1994) 1.05
Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats. Circulation (2000) 1.05
Quantitative analysis of collagen and collagen subtypes I, III, and V in human pancreatic cancer, tumor-associated chronic pancreatitis, and alcoholic chronic pancreatitis. Pancreas (1995) 1.05
Cold-active serine alkaline protease from the psychrotrophic bacterium Shewanella strain ac10: gene cloning and enzyme purification and characterization. Appl Environ Microbiol (1999) 1.05
Extrapontine myelinolysis presenting with parkinsonism as a sequel of rapid correction of hyponatraemia. J Neurol Neurosurg Psychiatry (1997) 1.05
Retracted Induction of monocyte chemoattractant protein 1 by Helicobacter pylori involves NF-kappaB. Infect Immun (2001) 1.04
Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1). Ann Rheum Dis (2007) 1.03
cDNA cloning, purification, and characterization of mouse liver selenocysteine lyase. Candidate for selenium delivery protein in selenoprotein synthesis. J Biol Chem (2000) 1.03
Discoidin domain receptor 1 isoform-a (DDR1alpha) promotes migration of leukocytes in three-dimensional collagen lattices. FASEB J (2001) 1.02
The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma. Br J Cancer (2006) 1.02
Prospective study on the relation of cigarette smoking with cancer of the liver and stomach in an endemic region. Int J Epidemiol (2000) 1.01
Recent topics in pyridoxal 5'-phosphate enzyme studies. Annu Rev Biochem (1990) 1.01
Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver. Clin Cancer Res (2000) 1.00
The purification, characterization, cloning and sequencing of the gene for a halostable and thermostable leucine dehydrogenase from Thermoactinomyces intermedius. Eur J Biochem (1994) 1.00
Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma. J Natl Cancer Inst (1993) 1.00
Individual and joint impact of family history and Helicobacter pylori infection on the risk of stomach cancer: a nested case-control study. Br J Cancer (2004) 0.99
A prospective study of stomach cancer death in relation to green tea consumption in Japan. Br J Cancer (2002) 0.99
Relationship between the consumption of toxic rice oil and the long-term concentration of polychlorinated biphenyls in the blood of yusho patients. Food Cosmet Toxicol (1981) 0.99
Induction of the S100 chemotactic protein, CP-10, in murine microvascular endothelial cells by proinflammatory stimuli. Blood (1997) 0.99
Chemokine production by human vascular smooth muscle cells: modulation by IL-13. Br J Pharmacol (1997) 0.99
Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J Neurosurg (1994) 0.99
IL-1 activation of endothelium supports VLA-4 (CD49d/CD29)-mediated monocyte transendothelial migration to C5a, MIP-1 alpha, RANTES, and PAF but inhibits migration to MCP-1: a regulatory role for endothelium-derived MCP-1. J Leukoc Biol (1995) 0.99
Evaluation of Helicobacter pylori vacA genotype in Japanese patients with gastric cancer. J Clin Pathol (1998) 0.98